Bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence of platinum-sensitive advanced ovarian cancer (terminated appraisal)

  • Technology appraisal
  • TA560
  • Published: 

Tools and resources

Guidance into practice